ISRG Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 28.41% compared to Intuitive Surgical's net margin of 12.41%. Intuitive Surgical's return on equity of 15.6% beat Boston Scientific's return on equity of 8.96%.

Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Boston Scientific has an analysts' consensus of $115.62 which suggests that it could grow by 19%. Given that Intuitive Surgical has higher upside potential than Boston Scientific, analysts believe Intuitive Surgical is more attractive than Boston Scientific.

Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.845%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Boston Scientific quarterly revenues of $4.6B. Intuitive Surgical's net income of $685.7M is higher than Boston Scientific's net income of $566M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Boston Scientific's PE ratio is 77.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 8.62x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Insulet has a net margin of 28.41% compared to Intuitive Surgical's net margin of 16.85%. Intuitive Surgical's return on equity of 15.6% beat Insulet's return on equity of 43.11%.

Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Insulet has an analysts' consensus of $314.06 which suggests that it could grow by 22.95%. Given that Intuitive Surgical has higher upside potential than Insulet, analysts believe Intuitive Surgical is more attractive than Insulet.

Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Insulet has a beta of 1.285, suggesting its more volatile than the S&P 500 by 28.544%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.4B, which are larger than Insulet quarterly revenues of $597.5M. Intuitive Surgical's net income of $685.7M is higher than Insulet's net income of $100.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Insulet's PE ratio is 44.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 9.11x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

Stryker has a net margin of 28.41% compared to Intuitive Surgical's net margin of 8.48%. Intuitive Surgical's return on equity of 15.6% beat Stryker's return on equity of 15.22%.

Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Stryker has an analysts' consensus of $424.43 which suggests that it could grow by 14.86%. Given that Intuitive Surgical has higher upside potential than Stryker, analysts believe Intuitive Surgical is more attractive than Stryker.

Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Stryker has a beta of 0.946, suggesting its less volatile than the S&P 500 by 5.393%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker offers a yield of 0.88% to investors and pays a quarterly dividend of $0.84 per share. Intuitive Surgical pays -- of its earnings as a dividend. Stryker pays out 40.73% of its earnings as a dividend. Stryker's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Stryker quarterly revenues of $6.4B. Intuitive Surgical's net income of $685.7M is higher than Stryker's net income of $546M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Stryker's PE ratio is 47.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 6.31x for Stryker. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 28.41% compared to Intuitive Surgical's net margin of -17.18%. Intuitive Surgical's return on equity of 15.6% beat Teleflex's return on equity of 1.57%.

Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Teleflex has an analysts' consensus of $168.21 which suggests that it could grow by 22.15%. Given that Intuitive Surgical has higher upside potential than Teleflex, analysts believe Intuitive Surgical is more attractive than Teleflex.

Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Teleflex has a beta of 1.211, suggesting its more volatile than the S&P 500 by 21.134%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex offers a yield of 0.99% to investors and pays a quarterly dividend of $0.34 per share. Intuitive Surgical pays -- of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.4B, which are larger than Teleflex quarterly revenues of $795.4M. Intuitive Surgical's net income of $685.7M is higher than Teleflex's net income of -$136.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Teleflex's PE ratio is 96.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 2.13x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.